The Risks and Benefits of Indacaterol

11 de novembro de 2012

The Indacaterol is one of the COPD medicines available at USA, Europe and Brazil. The NEJM in its editorial made some reflexion about the use of this drug about security and efficacy according FDA’s analysis.
The article is in the following link:
The Risks and benefits of Indacaterol – An FDA Review

%d blogueiros gostam disto: